A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Patil, L. S.
- Post-operative Pulmonary Complications after Elective Abdominal Surgery
Authors
1 Department of Surgical Oncology, S.S. Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
2 Department of Obstetrics and Gynecology, S.S. Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
3 Department of Forensic Medicine & Toxicology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
4 Dept. of Pharmacology, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
5 Department of Microbiology, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
Source
Indian Journal of Public Health Research & Development, Vol 3, No 1 (2012), Pagination: 114-117Abstract
The incidence of post operative pulmonary infection vary according to the definition of post operative complications and the surgical site.
Aim
Main aim is to study the incidence and various risk determinants of postoperative pulmonary complications following elective abdominal surgery.
Methodology
A total of 103 patients who had an elective abdominal surgery were assessed for complications.
Results
Among 103 patients, 24.27% developed postoperative pulmonary complications. More commonly the elderly men, obese, smokers, prolonged surgery time and midline vertical incision were other determinants for developing complications.
Conclusion
Adequate preoperative evaluation of pulmonary functions can reduce pulmonary morbidity in a high risk patient undergoing an elective abdominal surgery.
Keywords
Postoperative Complications, Pulmonary Complications
References
- Singh A, Purohit A, Joshi V, Sharma RS, Garg OP. Preoperative lung function tests. Best predictor to correlate post-operative pulmonary complications after upper abdominal surgery. Asian Archieves of Anaesthesiology and Resuscitation 1993;XXXIX(1).
- Bartholome R, Celli MD. What is the value of preoperative pulmonary function testing ? Medical clinics of North America 1993;309-325.
- Crozier TA, Sydow M, Siewart JR, Braun U. Post operative pulmonary complication Rate and Long Term changes in respiratory function following esophagogastrectomy with esophagogastrostomy. Acta Anaesthesiology Scand 1992; 36:10-15.
- Zibrak JD, O’Donnel CR, Marton K. Indications for pulmonary function testing. Annuals of Internal medicine. 1990;112(10).
- Latimer RG, Dickman M, Day WC et al. Ventilatory patterns and pulmonary complications after upper abdominal surgery determined by Pre-operative and post-operative computerized spirometry and blood gas analysis. Am J Surg 1971;122, 622.
- Park JE, Park K. Textbook of preventive and social medicine, 14th edition, Obesity 1998;255-258.
- Miller RD. Textbook of Anesthesia 4th edition.
- Wightman JAK. A prospective survey of the incidence of postoperative pulmonary complications. Br J Surg SS Feb 1998.
- Wylie, Churchill. Davidson’s – A practice of anaesthesia, 6th edition.
- A Two Year Study of Polycystic Ovary Syndrome in Davangere, Karnataka
Authors
1 Department of OBG, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
2 Department of Surgical Oncology, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
3 Department of Forensic Medicine & Toxicology, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
4 Dept. of Pharmacology, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
5 Dept. of Microbiology, S.S Institute of Medical Sciences and Research Centre, Davangere- 577005, Karnataka, IN
Source
Indian Journal of Public Health Research & Development, Vol 3, No 2 (2012), Pagination: 35-39Abstract
Introduction
Polycystic ovarian syndrome (PCOS) is one of the common gynaecological condition of diverse etiology 30% of the infertile women have anovulation due to polycystic ovarian disease, 20-30% of them have hyperandrogenemia and hyperprolactenemia1.
Methods
An explorative type of hospital based study of 102 patient, during a 2 year period was done with 75 (73.52%) married women and 27 (26.47%) unmarried women with varied symptomatology.
Results
67.6% were in the age group 21-30 years. Ovulation induction was done in all the infertile group, an ovulation induction rate of 88.40% was achieved and of these 21 (34.42%) conceived, others on follow up. Of the unmarried women, all had menstrual irregularities along with obesity (51.85%) and hirsutism (48.14%), after treatment 66.66% had an improvement in their symptoms, other still on follow up.
Conclusion
This study demonstrates the various presentations either single or in combination and their response to various medical and surgical management. There should be a rational approach to therapy, treatment of polycystic ovarian syndrome should be tailored according to the major symptoms of the patients.
References
- Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J, 1986;293:355-358.
- Robisnson S. et al. Which hormone tests for the diagnosis of polycystic ovary syndrome ? Bri J Obstet and Gynaecol, 1992;99:232-238.
- Campo, Sebastiano. Ovulatory cycles, pregnancy outcome and complications after surgical treatment of polycystic ovary syndrome. Obstet Gynaecol Survey, 1998;53(5):297-305.
- Shah D, Agarwal S. Polycystic ovarian syndrome in the Adolescent girl. J Obstet Gynaecol India, 1999;49(5):46-48.
- Rajan R. Endocrinology of PCOs : clinical presentation. Chap. 22, Postgraduate Reproductive Endocrinology, Jaypee Publishers, New Delhi, 4th edition. 1997. pg.325.
- Attaran M. Polycystic ovarian syndrome, Cleveland clinic, center for continuing education, 2008;1-8.
- Al-Ojaimi EH. Laparoscopic ovarian drilling for polyeystic ovarian syndrome in clomiphene resistant women with anovulatory infertility. Bahrian Med Bull; 2003;25(2):58-63.
- Rogerio LA. The role of neurotransmitters and opioids in polycystic ovarian syndrome. Endocrinol Metabol Clin North Am 1988;17(4):667.
- Gloria BA. Polycystic Ovary Syndrome : Metabolic challenges and new treatment options. Am J Obstet Gynaecol, 1998;179(6)2:S87-S113.
- Ardaens et al. Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertil Steril 1991;55(6):1062-1068.
- A Pilot Syudy of Relation of Polycystic Ovary Syndrome and Metabolic Disorder in Davangere, Karnataka
Authors
1 Department of Obstetrics and Gynaecology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
2 Department of Anatomy, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
3 Department of Forensic Medicine & Toxicology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
4 Department of Surgical Oncology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
Source
Indian Journal of Public Health Research & Development, Vol 3, No 2 (2012), Pagination: 40-44Abstract
Introduction
Polycystic ovarian syndrome (PCOS) is seen in 5 - 10% of women of the reproductive age, is the most common form of anovulatory infertility.
Evidence prove that these women exhibit a characteristic dyslipidaemia non insulin dependent diabetes and cardiovascular disease in later life, which are the hallmarks of the metabolic syndrome.
Presence of 3 of 5 common cardiovascular risk factors as a criteria, the prevalence of metabolic syndrome in PCOS is very high (43 - 46%).
Primary infertility cases with clinical features of menstrual irregularities, weight gain, hirsutism, acne and galactorrhea with scan picture of polycystic ovaries were considered for diagnosing PCOS cases.
Aim of the Study
Aim is to establish the relation between PCOS and metabolic syndrome.
Material and Methods
Study Design
A prospective, noninterventional case control study was conducted with 60 primary infertility patients, attending the gynaecological department, S.S. Institute of Medical Sciences and Research Centre, Davangere, Karnataka.
Study population
All these patients had clinical features suggestive of PCOS, of these 30 patients with ultrasound findings of polycystic ovaries were taken as cases and the others were age matched contemporary controls.
Age group: 20 - 30 years. Duration of study: 8 months. (Dec. 2009 - July 2010)
Methodology
After a brief history, waist circumference and blood pressure was recorded, then patients were asked to come on overnight fasting for a fasting blood sugar level and lipid profile assessment.
Results
In the present study all the five parameters needed for diagnosing metabolic syndrome were raised in PCOS cases and compared to controls. Values were statistically significant by student's unpaired 't' test.
An incidence of 38% of metabolic syndrome was noted in the PCOS cases studied.
Conclusion
Women with PCOS were strongly associated with metabolic syndrome when compared with the controls.
Obesity, high triglycerides and low high density lipoprotein levels are closely linked to insulin resistance and they are independent predictors of myocardial infarction and cardiovascular disease.
Results strongly indicate the need for comprehensive screening and education program for women of all ages with PCOS. Modification of lifestyle factors such as diet and exercise along with insulin sensitizers and lipid lowering agents can prevent long term health risks.
References
- Hull MGR. Epidemilogy of infertility and polycystic ovarian disease : endocrinological and demographic studies. Gynecol Endocrinol 1987;1(235-45).
- Adams J, Polson DW, Franks S. Prevalenceof polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;239:355-9.
- Frank S. Polycystic ovary syndroem. N Engl J Med 1995;333:853- 861.
- Glueck CJ, Papanna R, Wang P et al. Incidence and treatmetn of metabolic syndrome in newly referred women with confirmed polycystic ovary syndrome. Metabolism 2003;52:908-15.
- Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among us adults : findings from the third national health and trition examination survey. JAMA 2002;287:356-9.
- Attaran Marjan. Polycystic ovary syndrome, cleveland clinicmeded 2004;1-8.
- Conway G, Agarwal R, Betteridge DJ, Jacobs HS. Risk factors for coronary heart disease in lean and obese PCOS. Clin Endocrinol 1992;37:119-125.
- Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
- Faloia E, Canibus P, Gatti C, Frezza F, et al. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Invest 2004;27:424-9.
- Dahlgren E, Janson PO, Johansson S. Polycystic ovary syndrome and risk for myocardial infarction evaluated for a risk factor model based on a prospective study of women. Acta Obstet Gynecol Scand 1992;71:599-604.
- Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome : a prospective controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165-9.
- Gaziano JM, Hennekens CH, O’Donnell. Fasting triglycerides, high density lipoprotein and risk of myocardial infarction. Circulation 1997;96:2520-5.
- Maruyama C, Imamura K, Teramato T. Assessment of LDL particle size by triglyceride / HDL cholesterol ratio in nondiabetic heatlhy subjects. J Atheroscler Thromb 2003;10:186-91.
- McLaughlin T, Abbasi F, Cheal K, Chu J, et al. Use of metabolic markers identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-9.
- Brehm A, Pfeiler G, et al. Relationship between serum lipopotein ratios and insulin resistance in obesity. Clin Chem 2004;54:2316-22.
- Executive summary of the third report of the NECP, expert panel on detection, evaluation and treatment of high blood cholesterol in adults (ATP III). J Am Med Asso 2001;285:2486- 2497.
- Barnard RJ, Wen SJ. Exercise and diet in the prevention and control of the metabolic syndrome. Sports Med 1994;18:218- 28.
- Clinical Use and Safety of Medical Method of first Trimester Abortion
Authors
1 Department of Obstetrics and Gynaecology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
2 Department of Anatomy, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
3 Department of Forensic Medicine & Toxicology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
4 Department of Surgical Oncology, S.S.Institute of Medical Sciences & Research Centre, Davangere-577005, Karnataka, IN
Source
Indian Journal of Public Health Research & Development, Vol 3, No 2 (2012), Pagination: 45-48Abstract
Introduction
Women have a right to undergo an abortion if she wishes. Medical abortion is legally accepted under the Indian law. Mifepristone and misoprostol combination offers a safe, nonsurgical alternative for pregnancy termination with good success rates.
Aims and Objectives
The purpose of this study was to evaluation of the clinical efficacy of the combination of mifepristone and misoprostol orally for early termination of pregnancy.
Methods
A prospective clinical study conducted during a one year period included 100 healthy pregnant women consenting for a legal abortion with an ammenorrhoea of no more than 63 days.
Results
This method had a success rate of 94%, with an average induction abortion interval between 40-50 hours, one women needed surgical curettage. No serious side effects expect for nausea was noted.
Conclusion
The combination of mifepristone and misoprostol is effective for the termination of early pregnancy in terms of success, tolerance, safety and practicality.
References
- Manju MV. Jassawalla MJ. Manual ontermination of pregnancy, 3rd edn., 1999;9-11,55-59.
- WHO : Pregnancy termination with mifepristone and semeprost – A multicentre comparison between repeated doses and a single dose of mifepristone; fertile steril; 1991:56:32-40.
- Norman JE, Kelly RW, Glasler AF. Effects of Mifepristone in vivo on decidual prostaglandin synthesis and metabolism; contraception; 1991;49:88-89.
- Usha K. Antiprogesterons, today and tomarrow, review article. J Obs Gynec 2000;26-34.
- Wel SG et al. Termination of early pregnancy by two regimens of mifepristone with misoprostol and PGO5 – a multicentre randomized clinical trial in china; Contraception; 1994;50:501- 510.
- Birgerson L, Odlind V. Early pregnancy termination with antiprogestins : a comparative clinical study of Ru 486 given in two dose regimens and epostane, Fertil Steril 1987;48(4):565- 70.
- Remi P, Elisabeth A et al. Early termination of pregnancy with mifepristone and the orally active prostaglandin misoprostol, N Engl J Med 1993;328:1509-13.
- Bahzad C, Wyssling H, Saraya, Yougen S. Termination of early human pregnancy with mifepristone and the prostaglandin analogue sulprostone; a multicentre randomized comparison between two treatment regimens; Oxford J Human Reprod 1989;4(6):718-725.
- Beatrice C, LeNelly S, Andre U et al. Termination of early pregnancy by the progesterone antagonist Ru (486) Mifepristone, N Engl J Med, 1996;315:1565-1570.
- UK Multicentre trial : The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy, Br J Obstet Gynaecol; 1998;97:480-86.
- Florence D, Catherine D, Joelle B, Rene F. Efficacy of progesterone antagonist Ru 486 (Mifepristone) for preoperative cervical dilatation during first trimester abortion, Oxford J Human Reproduct 1988;3(5):583-84.
- Cross Sectional Survey of Burden of Illness in Terminally Ill Cancer Patients
Authors
1 Department of Surgical Oncology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
2 Department of Obstetrics and Gynecology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
3 Dept. of Pharmacology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
4 Department of Forensic Medicine & Toxicology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
5 Dept. of Microbiology, S.S. Institute of Medical Sciences & Research Centre Davangere 577005, Karnataka, IN
Source
Indian Journal of Public Health Research & Development, Vol 2, No 1 (2011), Pagination: 33-37Abstract
Introduction
Cancer is one of the leading causes of mortality in women, especially in the developing countries, where palliative care is not greatly emphasized.
Objectives
The primary objective is to analyse the various medical, ethical and legal issues faced by terminally ill gynaecological cancer patients. The other objectives being pain assessment, overall health related quality of life, economic issues and to determine preferences regarding decision making and information disclosure to patients.
Methods
A non interventional hospital based cross-sectional survey of 100 terminallly ill patients was conducted over a period of 2 years (March 2007 - April 2009).With an informed consent, the patient is asked to complete a questionaire.
Results-Medical problems
74% of patients had intolerable pain, so deprived of sound sleep. 98% of them suffered from some form of depression. Poor educational status and poverty made these patients highly dependable on family members for financial assistance (64%). Comparatively the more elderly patients experienced an inner fear, as they were neglected or abandoned by the care takers.
Ethical problems
With good doctor-patient relationship, communication about diagnosis and management was established in 50% of cases, but majority of them (81%) were not involved in decision making, which amounts to medical negligence.
Legal problems
None of the patients were aware of their legal rights during the course of their illness
References
- Dr. Partha Basu “Palliative care an integral part of cancer management”, Vol. VI, I, Indian Journal of Oncology, Page 5-13, (2006)
- Sepulveda et al., JPSM 2002,24:91-96.
- Reena George, “Evaluation of palliative care in developing countries”, Vol. II, I, Indian Journal of Palliative care, page 2-6 (2005).
- Ethical and legal issues surrounding palliative care, International conference on modern cancer management, July 2008;21-27.
- Euthanasia and physician assisted suicide, 2002, pg. 2-10, www.spuc.org.uk.
- www.worldtd.net/public/Israel_terminallyill_law.pdf
- Euthanasic and physician assisted suicide, 2002,pg 2- 10, www.spuc.org.uk.
- Pincombe et al (1997)
- Ethical and legal issues – International conference on modern cancer management, July 21-27, 2008.
- Current review of pain, Gerald et al. eds. Prithvi Raj, 2000.
- Christine faull et al., Handbook of palliative care, 2001.